Journal profile · Endocrinology & Metabolism
Best Practice & Research Clinical Endocrinology & Metabolism
ISSN 1521-690X · eISSN 1532-1908 · Bailliere Tindall Ltd · ENGLAND · Quarterly
Best Practice & Research Clinical Endocrinology & Metabolism: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 6.91; hybrid open access; APC about USD 4,450; review 6–12 weeks (community reports); community-reported acceptance: moderate; 69 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Best Practice & Research Clinical Endocrinology & Metabolism is published by Bailliere Tindall Ltd and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Growth Hormone and Insulin-like Growth Factors, Pituitary Gland Disorders and Treatments and Thyroid Disorders and Treatments, together about 24.7% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
Best Practice & Research Clinical Endocrinology & Metabolism is a topical serial publication integrating the results from the latest original research into practical, evidence-based review articles that seek to address the key clinical issues of diagnosis, treatment and patient management.Each issue follows a problem-orientated approach which focuses on the key questions to be addressed, clearly defining what is known and highlighting topics for future research. Management is described in practical terms so that it can be applied to the individual patient. The series is aimed at the physician either in practice or in training.In practical paperback format, each 200 page issue of Best Practice & Research Clinical Endocrinology & Metabolism provides a comprehensive review of clinical practice and thinking within one specific area of endocrinology and metabolism.Each issue, written by an international team of contributors and guest edited by a renowned expert, form part of a continuous update of current clinical practice.• Attractive format and two-colour text layout • Six issues published annually • Highlighting the latest 'best practice' and 'clinical evidence' • Topic-based, problem-orientated approach • Recommendations on diagnosis, treatment and patient managementThe objective of the series is to provide the physician with the most up-to-date source of information in the field.
From the journal's Aims & Scope
Research area (LetPub): Endocrinology & Metabolism
Editor-in-chief Philippe ChansonPublisher website
Editorial board by country: none in mainland China; most named United States 7, United Kingdom 5, France 4, Switzerland 2, Italy 1 (23 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Growth Hormone and Insulin-like Growth FactorsMedicine9.3%
- Pituitary Gland Disorders and TreatmentsMedicine8.7%
- Thyroid Disorders and TreatmentsMedicine6.7%
- Adrenal and Paraganglionic TumorsMedicine5.8%
- Sexual Differentiation and DisordersBiochemistry, Genetics and Molecular Biology5%
- Neuroendocrine Tumor Research AdvancesMedicine4.8%
- Adrenal Hormones and DisordersMedicine4.6%
- Thyroid Cancer Diagnosis and TreatmentMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Endocrinology & Metabolism | Zone 2 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Endocrinology & Metabolism | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Endocrinology & Metabolism | Zone 1 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 6.91LetPub ·
- Impact factor (publisher)
- 6.9Publisher website ·
- CiteScore 2026-06
- 12LetPub ·
- CiteScore (publisher)
- 12Publisher website ·
- SJR 2026-06
- 2.14LetPub ·
- SNIP 2026-06
- 2.2LetPub ·
- h-index
- 97LetPub ·
- h-index
- 153OpenAlex ·
- i10-index
- 1,344OpenAlex ·
- 2-year mean citedness
- 3.8OpenAlex ·
- Self-citation rate
- 1.4%LetPub ·
- Share of gold OA articles
- 33.73%LetPub ·
Volume
- Articles per year
- 55LetPub ·
Articles by year OpenAlex count · 1,890 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 54 | 15 | 15 |
| 2025 | 69 | 34 | 248 |
| 2024 | 50 | 23 | 395 |
| 2023 | 72 | 34 | 1,261 |
| 2022 | 75 | 30 | 2,038 |
| 2021 | 78 | 27 | 2,975 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- ModerateLetPub ·
- Acceptance to publication
- 3 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,450 / EUR 4,160 / GBP 3,560 / JPY 551,930 | — | — | |
| Publisher website | USD 4,510 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Abstract
- ≤ 250 words
- Graphical abstract
- Optional
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process. Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Bailliere Tindall Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Quarterly
- ISSN
- 1521-690X
- Electronic ISSN
- 1532-1908
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Best Practice & Research Clinical Endocrinology & Metabolism
What CAS zone is Best Practice & Research Clinical Endocrinology & Metabolism in?
In the 2025 upgraded edition of the CAS Journal Ranking, Best Practice & Research Clinical Endocrinology & Metabolism is in Zone 2 of Medicine, and in Zone 2 of the minor category Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Best Practice & Research Clinical Endocrinology & Metabolism?
The latest impact factor listed by LetPub is 6.91; CiteScore 12, h-index 153.
How long does peer review take at Best Practice & Research Clinical Endocrinology & Metabolism?
Authors report an average review time of 6–12 weeks; the community-reported acceptance is “Moderate”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Best Practice & Research Clinical Endocrinology & Metabolism?
According to the journal's author guidelines: Abstract: ≤ 250 words; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Best Practice & Research Clinical Endocrinology & Metabolism based?
Of the 23 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (7), United Kingdom (5) and France (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Best Practice & Research Clinical Endocrinology & Metabolism?
According to LetPub and DOAJ records, Best Practice & Research Clinical Endocrinology & Metabolism is indexed in SCIE and Scopus.
Is Best Practice & Research Clinical Endocrinology & Metabolism open access, and what is the APC?
Best Practice & Research Clinical Endocrinology & Metabolism is a hybrid journal. For open-access publication: APC about USD 4,450.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .